Partnership enables BIO-key technologies to be localized and delivered across Vietnam via SAVIS Group’s trusted services platformHANOI, Vietnam and HOLMDEL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, today announced a strategic partnership with SAVIS Group, one of Vietnam’s top information-technology enterprises, specializing in digital signing, identity verification, e ...

Core Insights - BIO-key International, Inc. has formed a strategic partnership with VaporVM to enhance its identity and access management solutions across the Middle East and Africa [1][2][4] Group 1: Partnership Overview - The collaboration aims to leverage VaporVM's cloud-native expertise and regional presence to deliver BIO-key's IAM solutions to various sectors [2][3] - VaporVM will integrate BIO-key's IAM and biometric solutions, providing local expertise and technical support [3][5] Group 2: Strategic Goals - The partnership is expected to strengthen cybersecurity measures for enterprises operating on major cloud platforms like AWS, Azure, and Google Cloud [3][4] - BIO-key's Regional Director emphasized the commitment to providing secure and scalable digital transformation solutions [4] Group 3: Company Background - BIO-key specializes in biometric-centric, multi-factor IAM software, securing access for over 40 million users [7] - The company's PortalGuard IAM solution offers various authentication methods, including passwordless options [7][9]

Core Insights - BIO-key International, Inc. has partnered with IT2Trust to enhance its presence in the Nordic market, focusing on delivering advanced Identity and Access Management (IAM) solutions with local expertise and cybersecurity leadership [1][2][5] Company Overview - BIO-key is a leader in biometric authentication and IAM solutions, securing access for over 40 million users with a range of authentication options including phoneless, tokenless, and passwordless methods [6] - IT2Trust is a prominent distributor of IT security and networking solutions in Scandinavia, providing consulting, training, and support services to strengthen digital resilience and compliance for enterprises and public organizations [5] Partnership Details - The collaboration will enable IT2Trust to distribute and support BIO-key's full portfolio of IAM and biometric authentication products, enhancing identity protection and regulatory compliance across Denmark, Sweden, Norway, and Finland [2][3] - This partnership is seen as a natural progression in BIO-key's European growth strategy, combining local market knowledge with global innovation to help organizations protect their data and digital future [5] Product Offerings - BIO-key's IAM solutions include PortalGuard, a comprehensive platform supporting multi-factor authentication (MFA), single sign-on (SSO), and centralized access management [8] - Other products include Passkey:YOU™, a FIDO2-compliant passwordless solution, and Identity-Bound Biometrics (IBB), which binds access to the individual rather than the device [8]

Financial Data and Key Metrics Changes - Company reported a solid Q2 performance with revenue rising 49% year-over-year to $1.7 million from $1.1 million in Q2 2024, and a sequential increase of 6% [4][12] - Gross profit increased by $354,000 or 40% to $1.2 million, although gross margin declined to 73% from 77% due to a higher percentage of lower-margin hardware sales [13] - Net loss improved to $1.2 million or $0.20 per share from a net loss of $1.7 million or $1 per share in Q2 2024 [13][14] Business Line Data and Key Metrics Changes - Hardware revenue increased significantly by $458,000, primarily due to additional deployments of biometric scanners for a long-time customer [12] - License fee revenue grew by 4%, reflecting an increase in subscription contracts, while service revenue rose by 11% due to customer service for a large upgrade [12] Market Data and Key Metrics Changes - The company is focusing on expanding its presence in the defense intelligence market, particularly in Europe, where military and defense investments are expected to increase significantly [6][8] - The EU plans to mobilize over €800 billion in defense investment over the next four years, with NATO members agreeing to increase defense spending to at least 5% of GDP by 2035 [6][7] Company Strategy and Development Direction - The company announced the formation of the BIO key cyber defense initiatives to expand market reach and engage with leading defense contractors [6] - There is a strategic refocus on BIO key branded solutions, moving away from previous licensed solutions, which is expected to enhance margins and growth opportunities [9] - The company is revitalizing its North American sales efforts and returning to an in-office model for sales and marketing teams [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential for growth in the defense and intelligence markets, citing robust contract activity and a strong pipeline [21][30] - The company believes that the current stock price does not reflect its performance and future opportunities, with expectations for revenue generation from contracts already closed [26][29] Other Important Information - The company is actively seeking opportunities to reduce costs to lower its breakeven level and support a path to positive cash flow and profitability [11] - Current assets as of June 30, 2025, were reported at $4 million, including $2.3 million in cash, an increase from $1.9 million at year-end 2024 [15] Q&A Session Summary Question: Should we expect the recent trend towards reduced operating expenses to reverse? - Management indicated that the recent increase in expenses was a temporary blip due to restructuring and event timing, and they expect to maintain the expense run rate moving forward [17][19] Question: Can you provide additional color on meaningful contract activity in the first half of next year? - Management confirmed that they have closed contracts that will generate revenue in Q3 and emphasized the robust market for their specific solutions [20][21] Question: Do you expect these contracts to ramp up significantly? - Management affirmed that they expect iterative growth from these contracts, with opportunities increasing in size and quantity [30][31] Question: How much of the reserve inventory did you sell? - Management stated that they are selling inventory every quarter and aim to move the bulk of it by the end of the year [36] Question: Do you think you have enough cash to get through the end of the year? - Management confirmed that they have sufficient cash and equivalents to sustain operations through the end of the year [44]